Global Sugar-Based Excipients Market Size (2024 - 2029)

The sugar-based excipients market is anticipated to experience growth due to the increasing demand for co-processed excipients and the rapid expansion of the generic market, alongside the development of orally disintegrating tablets. The market's expansion is further supported by the use of sugar-based excipients in COVID-19 vaccine formulations, which initially posed challenges during the pandemic but later contributed to market growth. The preference for orally disintegrating tablets, particularly among geriatric and pediatric populations, is driving demand, as these formulations benefit from the solubility and taste-enhancing properties of sugars and sugar alcohols. Despite these growth drivers, stringent regulatory requirements for sugar-based excipient products may pose challenges to market expansion.

Market Size of Global Sugar-Based Excipients Industry

Sugar-Based Excipients Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 4.60 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Low

Major Players

Sugar-Based Excipients Market Major Players

*Disclaimer: Major Players sorted in no particular order

Sugar-Based Excipients Market Analysis

The sugar-based excipients market is projected to grow with a CAGR of 4.6% over the forecast period.

During the COVID-19 pandemic, pharmaceutical excipients companies faced significant problems, such as a shortage of medicinal items, and shutdown measures worldwide damaged the global supply chain of raw materials from manufacturing hubs. These restrictions hampered the medication research and manufacturing processes and had a significant impact on the corporations that rely on outsourcing. Moreover, the growing use of sugar-based excipients in the COVID-19 vaccines positively impacted the market. For instance, according to the review by the Connecticut Department of Health in April 2021, the Pfizer-BioNTech vaccine contains basic table sugar, generally known as sucrose, which is used as a stabilizer in vaccines. This component aids in the preservation of the molecules' form upon freezing. Thus, during the COVID-19 pandemic, the sugar-based excipients market is expected to have an adverse impact initially, later due to the use of sugar-based excipients in COVID-19 drug and vaccine formulations which is likely to gain market growth over the study period.

The major factor attributing to the growth of the market is the increasing use of co-processed excipients, the rapid growth of the generic market, and the increasing development of orally disintegrating tablets. For instance, as per the report published by the journal of APhP in December 2022, new combinations of existing excipients are an interesting option for improving excipient functionality which includes pleasant taste, mouth feel, and sweetness in orally disintegrating tablets. Thus, due to the above benefits of the co-processed excipient, the demand for sugar-based excipients is expected to grow, as it is one of the ingredients in the pharmaceutical product, thereby boosting the market growth.

Furthermore, the growing preference for orally disintegrating tablets and their development is boosting the market. Orally disintegrating tablets differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. As the number of geriatric population and pediatric patients increases, the demand for orally disintegrating tablets is increasing. For instance, according to the study published by MDPI in August 2022, saccharides and sugar alcohols have long been of interest in the area of orodispersible formulations due to their high-water solubility and taste-improving properties. As a result, several excipient combinations developed to manufacture orally dispersible dosage forms contain monosaccharides and/or their respective alcohols. Sugars or sugar alcohols, together with other excipients, are used to ensure the tablets' uniformity and structural integrity. The market for sugar-based excipients is therefore projected to rise as a result of the aforementioned advantages of sugar-based excipients in orally dispersible tablets.

However, the stringent regulatory requirements for sugar-based excipient products are expected to restrain market growth.

Sugar-Based Excipients Industry Segmentation

As per the scope of the report, the excipient is a pharmacologically inert element formulated together with the active ingredient of the medication. This is done with the purpose of providing substance to the formulation, providing prevention and stability from denaturation, facilitating the absorption of drugs by a patient, and other pharmacokinetic considerations. The Sugar-Based Excipients Market is segmented by Product (Actual sugar, Sugar alcohols, and Artificial sweeteners), Type (Powders/Granules, Direct compression sugars, Crystals, and Others), Application (Fillers and Diluents, Flavoring agents, Tonicity agents, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product
Actual Sugar
Sugar Alcohols
Artificial Sweeteners
By Type
Powders/Granules
Direct Compression Sugars
Crystals
Others
By Application
Fillers and Diluents
Flavoring Agents
Tonicity Agents
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Sugar-Based Excipients Market Size Summary

The sugar-based excipients market is anticipated to experience steady growth over the forecast period, driven by several key factors. The increasing utilization of sugar-based excipients in pharmaceutical applications, particularly in the development of orally disintegrating tablets, is a significant contributor to market expansion. These excipients are valued for their ability to enhance taste and mouthfeel, making them ideal for formulations aimed at pediatric and geriatric populations. The market's growth is further supported by the rising demand for co-processed excipients, which offer improved functionality in drug formulations. Despite initial challenges posed by the COVID-19 pandemic, such as supply chain disruptions, the market benefited from the incorporation of sugar-based excipients in vaccine formulations, which helped stabilize the molecules during storage and transportation.

Regionally, North America is expected to witness substantial growth in the sugar-based excipients market, bolstered by a robust pharmaceutical sector and technological advancements. The presence of major industry players and strategic initiatives, such as product launches and expansions, are likely to enhance market dynamics in this region. The sugar alcohol segment, known for its non-toxicity and effectiveness in oral formulations, is projected to hold a significant share of the market, driven by its widespread use in pediatric medicines. However, the market faces challenges from stringent regulatory requirements governing the use of sugar-based excipients. Overall, the market is moderately competitive, with key players like DFE Pharma, Archer Daniels Midland Company, and Roquette Group leading the industry through innovation and strategic growth initiatives.

Explore More

Global Sugar-Based Excipients Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Use of Co-processed Excipients

      2. 1.2.2 Rapid Growth in the Generics Market

      3. 1.2.3 Increasing Development of Orally Disintegrating Tablets

    3. 1.3 Market Restraints

      1. 1.3.1 Stringent Regulatory Requirements

    4. 1.4 Porter Five Forces

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Product

      1. 2.1.1 Actual Sugar

      2. 2.1.2 Sugar Alcohols

      3. 2.1.3 Artificial Sweeteners

    2. 2.2 By Type

      1. 2.2.1 Powders/Granules

      2. 2.2.2 Direct Compression Sugars

      3. 2.2.3 Crystals

      4. 2.2.4 Others

    3. 2.3 By Application

      1. 2.3.1 Fillers and Diluents

      2. 2.3.2 Flavoring Agents

      3. 2.3.3 Tonicity Agents

      4. 2.3.4 Others

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Global Sugar-Based Excipients Market Size FAQs

The Global Sugar-Based Excipients Market is projected to register a CAGR of 4.60% during the forecast period (2024-2029)

Archer Daniels Midland Company, Ashland Inc., Roquette Group, The Lubrizol Corporation and DFE Pharma are the major companies operating in the Global Sugar-Based Excipients Market.

Sugar-Based Excipients Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)